DR. WILLIAM DAVID SCHWIETERMAN, M.D.
Osteopathic Medicine at Point Rd, Mobile, AL
License number
Alabama MD.24669
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
3901 Point Rd, Mobile, AL 36619
Phone
(251) 665-9224
(251) 662-3493 (Fax)
(251) 662-3493 (Fax)
Personal information
See more information about WILLIAM DAVID SCHWIETERMAN at radaris.comName
Address
Phone
3901 Point Rd, Mobile, AL 36619
4357 Shan Dr, Mobile, AL 36693
Mobile, AL
4357 Shan Dr S, Mobile, AL 36693
Professional information
See more information about WILLIAM DAVID SCHWIETERMAN at trustoria.com
President At Tekgenics
President At Tekgenics
Location:
Mobile, Alabama Area
Industry:
Pharmaceuticals
Dr. William D Schwieterman, Mobile AL - MD (Doctor of Medicine)
Dr. William D Schwieterman, Mobile AL - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
3901 Point Rd, Mobile 36619
(251) 665-9224 (Phone), (251) 662-3493 (Fax)
(251) 665-9224 (Phone), (251) 662-3493 (Fax)
Certifications:
Internal Medicine, 1988, Rheumatology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Cincinnati / Main Campus
Mount Sinai Hospital
Natl Inst Hlth
University Of Cincinnati / Main Campus
Mount Sinai Hospital
Natl Inst Hlth
Postural Stability And Incident Functions In Patients
Postural Stability And Incident Functions In Patients
US Patent:
2013019, Aug 1, 2013
Filed:
Jan 30, 2013
Appl. No.:
13/754001
Inventors:
Chelsea Therapeutics, Inc. - Charlotte NC, US
William Schwieterman - Mobile AL, US
Cameron Szakacs - Charlotte NC, US
Gerry Rowse - Waxhaw NC, US
Christopher Cioffi - Charlotte NC, US
Michael J. Roberts - Charlotte NC, US
William Schwieterman - Mobile AL, US
Cameron Szakacs - Charlotte NC, US
Gerry Rowse - Waxhaw NC, US
Christopher Cioffi - Charlotte NC, US
Michael J. Roberts - Charlotte NC, US
Assignee:
Chelsea Therapeutics, Inc. - Charlotte NC
International Classification:
A61K 31/198, A61K 45/06
US Classification:
514567
Abstract:
The present invention provides methods and systems for reducing falls in patients that are recurrent fallers. Specifically, the compositions, systems, and methods can relate to Parkinson's disease patients, particularly such patients that are suffering from neurogenic orthostatic hypotension. The compositions, systems, and methods comprise the use of droxidopa, optionally in combination with a further active agent. Administration of droxidopa has been found to reduce the mean number of falls per patient per week, as well as provide improvements in the patient's Hoehn and Yahr rating scale score, which is indicative of improvements in postural stability, and provide improvements in the patient's Unified Parkinson's disease Rating Scale score, which is indicative of improvements in the severity of motor and/or non-motor symptoms of Parkinson's disease.
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits
US Patent:
2013012, May 16, 2013
Filed:
Dec 13, 2012
Appl. No.:
13/714052
Inventors:
Edward A. Kesicki - Bothwell WA, US
Carl G. Osborne - Jacksonville FL, US
William D. Schwieterman - Mobile AL, US
Irina Jacobson - Sammamish WA, US
Carl G. Osborne - Jacksonville FL, US
William D. Schwieterman - Mobile AL, US
Irina Jacobson - Sammamish WA, US
Assignee:
NEUMEDICS - Seattle WA
International Classification:
A61K 31/65, A61K 45/06, C07D 498/10, C07C 233/58, C07D 265/34, C07D 263/52
US Classification:
514154, 544 99, 514152, 548221, 548216, 552200, 435 32, 435 15, 435 29
Abstract:
The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a fifth ring joining positions 9 and 10.
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits
US Patent:
2010000, Jan 14, 2010
Filed:
Jul 10, 2009
Appl. No.:
12/501202
Inventors:
Iain W. Duncan - Seattle WA, US
Edward A. Kesicki - Bothell WA, US
Carl G. Osborne - Jacksonville FL, US
William D. Schwieterman - Mobile AL, US
Irina Jacobson - Sammamish WA, US
Edward A. Kesicki - Bothell WA, US
Carl G. Osborne - Jacksonville FL, US
William D. Schwieterman - Mobile AL, US
Irina Jacobson - Sammamish WA, US
Assignee:
Neumedics - Seattle WA
International Classification:
A61K 31/536, A61K 31/423
US Classification:
5142295, 514375
Abstract:
The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a fifth ring joining positions 9 and 10.